लोड हो रहा है...
Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague
Yersinia pestis, the causative agent of pneumonic plague, induces a highly lethal infection if left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however, USAMRIID has developed a recombinant fusion protein, F1-V, that has been shown to induce protection against pneum...
में बचाया:
| में प्रकाशित: | Acta Biomater |
|---|---|
| मुख्य लेखकों: | , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7012387/ https://ncbi.nlm.nih.gov/pubmed/31610342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.actbio.2019.10.016 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|